Multiple, diffuse schwannomas in a RASopathy phenotype patient with germline KRAS mutation: a causal relationship?
D R
DR
Bertola
A C
AC
Pereira
A C
AC
Brasil
L
L
Suzuki
C
C
Leite
R
R
Falzoni
U
U
Tannuri
A B
AB
Poplawski
K M
KM
Janowski
C A
CA
Kim
L M
LM
Messiaen
D002648:Child; D002868:Chromosomal Proteins, Non-Histone / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics; D005260:Female; D018095:Germ-Line Mutation; D006801:Humans; D009442:Neurilemmoma / Q000235:genetics*; D025581:Neurofibromin 2 / Q000235:genetics; D010641:Phenotype; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D000071796:SMARCB1 Protein; D014157:Transcription Factors / Q000235:genetics; D055815:Young Adult; D018631:ras Proteins / Q000235:genetics*
D002868:Chromosomal Proteins, Non-Histone; D004268:DNA-Binding Proteins; C117307:KRAS protein, human; D025581:Neurofibromin 2; D011518:Proto-Oncogene Proteins; D000071796:SMARCB1 Protein; C513266:SMARCB1 protein, human; D014157:Transcription Factors; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins